Abstract: Doppel is a newly recognized prion-like molecule encoded by a novel gene locus, PRND, located on the same chromosomal region of the prion (PRNP) coding gene. Doppel was considered a paralogue and the first member of the prion-gene family, possibly originated through an ancestral gene duplication event. Prion and doppel have different expression patterns, suggesting that the gene products exhibit different biological functions. Actually, doppel is not involved in the aetiology of the Transmissible Spongiform Encephalopathies (TSEs) or "prion diseases" and is highly expressed only within the testicular tissue, suggesting an important physiological role in the process of spermatogenesis. The restricted spatial and temporal expression profile of doppel has suggested its investigation within particular pathological contexts, such as cancers, showing that it might represent a novel and attractive diagnostic molecular marker and that might provide insights into the regulatory pathways of tumor-cell transformation.
of the "Prion theory", originally formulated by Prusiner [1] ; b) the first prion-like gene was discovered and initially characterized, exactly at the end of 1999.
The concept of the possible existence of a "holy-grail" protein X, as an unidentified cellular co-factor essential to promote the conversion of the host encoded prion protein into its pathological isoform, was clearly defined within the prion scientists, from its original proposal [2] to the present day. These considerations were convincing enough to motivate scientists to challenge the novel discovered doppel gene within the background of specific prion-designed experiments. In particular, different genomic projects were aimed to better characterize the prion locus (PRNP ) in mammals: the rationale was to find regulatory elements and gene sequences that might influence or contribute to the abnormal expression of the pathological isoform of the prion protein. Due to the innovative concepts that developed the "Prion theory", based on an induced pathological conversion of a native prion protein to an isoform with a different structure, genomic studies on the prion gene were not of the highest priority. However, one of these genomic projects was particularly fruitful in determining the complete nucleotide sequence of a cosmid clone containing the murine prion gene. Surprisingly, at about 16 kb downstream of the prion gene an attractive open reading frame was highlighted in the pioneering paper of Moore and collaborators [3] . This novel gene sequence, additionally predicted with bioinformatics approaches, shared common genomic features with the prion gene, including the structure of the genes and the transcripts. However, the nucleotide similarities between the prion and the novel gene were quite low, despite the similar protein structures. Thus, it was logical to name the novel gene sequence as prion-doppel (doppel for downstream of prion protein complex) or in a more erudite fashion, doppelganger (from the German, "ghostlike companion"). In particular, the predicted gene possessed similar exon-architecture to that of the prion gene, with very short upstream exons and larger ones containing the entire coding sequences. Then, Moore and collaborators demonstrated that this open reading frame encoded the doppel (Dpl) protein. Also, another fundamental milestone was the initial definition of the spatial and temporal expression patterns of the gene expression: doppel appeared to be expressed only in testicular tissue and markedly not in the Central Nervous System (CNS), which differs from the expression patterns of its neighbour, the prion gene.
The next studies aimed to define the expression profiles of doppel in different tissues of mammals. This work confirmed that the gene was highly expressed in testes and nearly undetectable in brain and spinal cord tissues [4, 5] , which mirrored earlier studies in murine tissues. Another study showed a peculiar temporal expression pattern of doppel in the brain of neonatal wild-type mice, showing maximal expression around one week after birth [6] . Furthermore, the co-localization of the Dpl protein with specific bloodvessel endothelial cell markers, suggested a role of doppel in angiogenesis [6] . But before clarifying the restricted doppel expression patterns, the first doppel-study focused the attention to a particular aspect of the phenotype deriving from the doppel overexpression in murine mice. The ectopic expression of Dpl in the brain of mice was in fact responsible for ataxia and Purkinje cells' neurodegeneration in the cerebellum. However, this phenotype, manifested in a particular transgenic murine line (i.e. Rcm0), resulted from the absence of the host prion gene, consequently generating a prion knock-out Prnp 0/0 line. Schematically, the transgenic construct was characterised by the removal of the entire coding sequence of the prion gene but, additionally, with the deletion of the splicing acceptor donor site at the end of the second Prnp intron. Consequently, the transgenic line did not express the prion messenger as well as its protein product, PrP. However, as a result of a generated intergenic splicing, doppel was actively transcribed under the control of the strong prion-promoter regulatory sequences resulting in elevated expression of Dpl. Initially, it was speculated that Dpl had a role in pathogenicity or toxicity and that the prion protein has a potential protective role. However, most discussions targeted the different behaviour of prion-knock-out mice produced so far. Some of them (Zurich I and Edinburgh I), as discussed by Weissman and Aguzzi [7] , did not exhibited the ataxic phenotype, since no intergenic splicing events were generated. Others, such as Rcm0, Nagasaki and Zurich II, showed the peculiar ectopic expression of the doppel protein and neurodegenerative signs. This comparison finally shed light on the scientific debate originated on the opposite phenotypes (i.e. normal versus ataxic development) observed in prion-ablated transgenic mice.
The prion-gene family
Initial studies focussed on the detailed characterization of the doppel gene product and the analysis of biochemical similarities with prion. These contributions defined Dpl as a glycosylated glycosyl-phosphatidyl-inositol (GPI) anchored protein, located on the cell surface as PrP, but having a structural difference with two di-sulfide bridges instead of the single bound, typical of PrP [8, 9] (Figure 1 ). The predicted difference in structural stability between Dpl and PrP was markedly important if Dpl might undergo any conformational change from a physiological to a pathological status. This is analogous to the proposed transition of PrP C (cellular-PrP) to PrP Sc (scrapie-or pathological-PrP), originally formulated by Prusiner [1] . Nuclear Magnetic Resonance (NMR) studies on PrP [10] and Dpl [11] , highlighted in Figure 1 , as well as other important biochemical contributions [12] [13] [14] , proposed that Dpl was unlikely to adopt stable alternative PrP Sclike pathological isoforms. These studies elucidated that Dpl resembled PrP protein, although certain molecular signatures exhibited important differences. In particular, Dpl might be considered a truncated PrP, lacking the octapeptide repeat region, located at the N-terminal portion of the prion protein and important in copper ions binding [15] . These observations enabled the researchers to interpret previous results of ataxic transgenic mice expressing an N-terminal truncated form of PrP (PrPΔ32-134), a protein with molecular and biochemical similarities to the later discovered Dpl protein. [17] , showing that the Dpl-induced ataxic condition might be reversed by the reintroduction in transgenic mice of a wild-type copy of the prion gene and restoring its constitutive expression, as previously documented [16] . A subsequent contribution demonstrated again that this pathological phenotype might be stoichiometrically abrogated by the expression of the prion protein [18] . These results raised questions and opinions on the functions of these two proteins, on their antagonistic roles within the cells [19] and, of course, on the evolutionary meaning of their functional divergence [20] . [57] ) are coloured according to secondary structure features.
Looking for doppel functions
Novel genomic efforts, through sequencing and comparative genomics, were devoted to highlight the doppel gene variability in different species, particularly those affected by the Transmissible Spongiform Encephalophaties (TSEs) or prion diseases. In particular, after the characterization of the doppel gene in sheep and cattle [4, 21] , more recently in goat [22] and in humans [23, 24] , the nucleotide sequencing of the doppel coding regions identified few genetic polymorphisms (Table 1) . However, none appeared to be associated with the pathological status, neither in animals nor in humans. Conversely, other reports highlighted a weak association of a doppel polymorphism at codon 174 of the mature protein with the pathological status in Creutzfeldt-Jacob disease (CJD), a human prion disease, as well as in Alzheimer's affected patients [25] . Additional studies indicated absence of association between doppel haplotypes and Alzheimer disease [24] . These negative or contradictory evidences were then reinforced by the work of Tuzi and collaborators [26] and Peoc'h and co-workers [27] demonstrating that the expression of doppel in the CNS of mice and cultures cells, did not modulate the onset and the course of the disease. Further studies aimed to clarify the pathological details of the doppel-induced degeneration in transgenic mice, suggesting again that the rescue of the neurodegeneration, induced by the re-expression of PrP, argued for a possible interaction of the two proteins or the participation to a common cellular pathway [28] . To address these hypotheses different functional assays were performed. Unfortunately, while many protein partners were evidenced for PrP [29, 30] and Dpl [31] [32] [33] , no interaction was clearly exhaustive to decipher their common functional role within the cell.
In an attempt to elucidate a functional role, the doppel gene was deeply investigated within the testis, the tissue that showed its highest expression in vivo. Pivotal contributions [34, 35] identified that the protein was highly expressed in both Sertoli cells and spermatozoa. Furthermore, doppel ablation was not lethal to mice and animals developed normally, except that males were sterile, with their spermatozoa unable to fertilize egg cells without the removal of the zona pellucida [34] . Further refinements on the doppel expression in the reproductive trait were later introduced in mice [36] , in humans [37, 38] , in sheep [39] and in cattle [40] . Prion and doppel double knock-out mice were also produced, excluding a potential role for the prion protein in spermiogenesis [38] .
Regardless of the pathogenic properties of the Dpl protein in transgenic mice, studies performed on cell models showed that, in general, Dpl was toxic to neurons [41] and the enhanced expression of the protein exacerbated oxidative stress conditions, leading to the release of reactive HO-1 and NOS species in mice devoid of PrP protein [42] . More recently, in a published contribution by Qin and collaborators [43] , the ectopic expression of the doppel protein in murine neuroblastoma and astrocytes was shown to be responsible for induction of the apoptotic cascade, through the activation of caspase-10 and caspase-3 pathways. Additionally, this effect was counteracted by increased expression levels of the prion protein.
By comparing the prion and doppel expression profiles, as stated above, important differences were documented. In particular, Makrinou and collaborators [5] exhibited transcriptional expression evidences, with the prion being expressed at high levels in many tissues and with doppel expressed only in the testicular tissue at significantly levels. The reasons for these differences were mainly investigated through the analysis of their respective promoter regions in different species. In detail, the prion gene in mammals was shown to be regulated by a strong promoter, which was adopted in the construction of reporter expression plasmids [44] . The basic structure of the prion-promoter region consisted of four conserved short nucleotide motifs. However, as reported in different contributions [45] [46] [47] [48] , the doppel promoter did not show any of the prion promoter motifs, lacking also the typical eukaryotic TATA and CpG islands. These characteristics, together with the possible binding of regulatory molecules (Brn-3a and Brn-3b), the presence of cis-acting elements (CCAAT and E boxes) as well as the interaction with inhibitory elements, might reflect a complex and modulated transcription capability to the doppel promoter.
Despite much evidence describing the ataxic Dpl-induced phenotype in transgenic mice, the Dpl temporal and spatial expression profile and the function/s of the gene within the cell is still missing. However, this is not surprising at all, since the function of the prion gene itself remains contentious.
Novel pathological doppel scenarios
In 2004, two different contributions enlarged the spectrum of interest around the doppel gene. Ferrer and collaborators [49] investigated the expression of Dpl in a pathological context different from prion diseases. Specifically, the authors identified the presence of Dpl immunoreactivity in dystrofic neurites of senile plaques in Alzheimer's patients. These results were interpreted by the authors suggesting that Dpl might have the capacity to trigger the astrocytic and microglial response to the pathological accumulation of amyloid deposits in the affected patients. Analogously, a different pathological context was investigated by Comincini and co-workers [50] , specifically the expression of the doppel gene in CNS tumours. The rational was to identify any differences in expression from the low and nearly undetectable level of doppel expression in healthy brain tissues versus the pathological or neoplastic tissues. Surprisingly, in the most diffused CNS tumours, i.e. the astrocytomas or glial tumours, doppel showed high level of expression that paralleled with the increase of the tumour malignancy grade. In particular, the transcript exhibited a peculiar nuclear retention and, perhaps as a consequence, the corresponding protein accumulated in the cell cytoplasm, altering its trafficking and losing the plasma membrane GPI-anchored localization [51] . Importantly, since tumor cells in gliomas exhibited expression of proteins that are normally produced at different developmental stages in astrocytic differentiation pathways, the high expression profiles of doppel in the first stages of development [6] and in gliomas [50] may indicate the neoplastic cell's re-acquisition of a "primitive" expression behaviour, typical of the CNS development.
The diagnostic and prognostic role of doppel expression was also exploited in a different tumour context, specifically in myelodisplastic-to-leukaemia cancer progression. Travaglino and collaborators [52] identified an increased population of blast cells expressing Dpl in bone marrow of affected patients. These Dpl-immunoreactive cells were shown to be stem-like CD34 positive. Clinically, the expression of Dpl was significantly higher in leukaemic patients compared to the initial stages of the neoplastic transformation in the myelodisplastic and to the healthy bone marrow controls, where Dpl was barely detectable. In this contribution, the authors suggested that doppel might be considered a novel leukaemia-associated antigen, useful for diagnostic and therapeutic purposes. However, the studies describing the ectopic expression of the doppel gene in cancers have to address and clarify the pathological consequences of its expression in the course of the transformation events; doppel expression could be involved in determining typical properties of the tumour cells, like uncontrolled proliferation, apoptosis, migration or adhesion. One fascinating scenario, particularly attractive in the glial tumours, might be the loss of antigenicity of the tumour cells, due to the loss of expression at the cellular outer membrane of particular proteins like Dpl.
In addition, the ectopic expression of the doppel gene in tumours resembled in part those genes collectively defined as cancer testis (CT) antigens; these represent a unique class of tumour antigens, which are expressed in a variety of cancerous tissues and are silent in normal tissues, except for the testis. Owing to their restricted gene expression in the testis and various malignancies, CT antigens represent potential defined targets for antigen-based vaccination and antigen-directed immunotherapy to control cancer growth [53] . The similarities between CT and Dpl resided in their very restricted pattern of expression, precisely in testes and tumours, and, to same extent, in their gene architecture, forming gene-families through ancestral gene-duplication events. Hence, prion and doppel gene were thought to derive from an ancestral duplication event that might be tentatively dated after the divergence of fish from tetrapods [54, 55] . Furthermore, extensive genomic researches identified novel putative additional members of the prion gene family, such as PRNT [5] and Shadoo [56] , even if a finer molecular and biochemical characterization of the gene products is still missing.
Future perspective
In conclusion, regardless of the number of genes that might be reasonably included in the prion-gene family, the advent of the doppel discovery represents, until now, the most comprehensive identification and characterization of a prion-related gene. Unfortunately, its identification offered a modest contribution to the complete understanding and to a final definition of the "Prion-theory". A contribution in this field, not completely marginal, was the molecular characterisation of the different phenotypes of prion knock-out mice lines. On the other hand, we feel that at least two different biological contexts merit to be investigated for the doppel gene: the physiological process of fertilization, in particular the maturation of spermatozoa and the interaction between spermatozoa and egg cells, and the pathological neoplastic cell transformation, where doppel might represent a novel and attractive molecular marker. However, the research studies on doppel are still in their infancy and it is reasonable to wait for some years and for additional scientific journeys to shed light on these complex biological events.
